As of 2026-10-01, the Relative Valuation of Crinetics Pharmaceuticals Inc (CRNX) is (101.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 84.95 USD, the upside of Crinetics Pharmaceuticals Inc based on Relative Valuation is -219.4%.
The range of the Relative Valuation is (87.20) - (123.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.4x - 26.0x | 22.2x |
| Forward P/E multiples | 15.1x - 26.1x | 20.6x |
| Fair Price | (87.20) - (123.22) | (101.42) |
| Upside | -202.7% - -245.1% | -219.4% |
| Date | P/E |
| 2026-08-31 | -17.92 |
| 2026-08-28 | -17.90 |
| 2026-08-27 | -17.90 |
| 2026-08-26 | -17.90 |
| 2026-08-25 | -17.91 |
| 2026-08-24 | -17.89 |
| 2026-08-21 | -17.87 |
| 2026-08-20 | -17.87 |
| 2026-08-19 | -17.87 |
| 2026-08-18 | -17.88 |
| 2026-08-17 | -17.88 |
| 2026-08-14 | -17.87 |
| 2026-08-13 | -17.82 |
| 2026-08-12 | -17.82 |
| 2026-08-11 | -17.80 |
| 2026-08-10 | -17.76 |
| 2026-08-07 | -17.74 |
| 2026-08-06 | -17.71 |
| 2026-08-05 | -17.72 |
| 2026-08-04 | -17.69 |
| 2026-08-03 | -17.67 |
| 2026-07-31 | -17.62 |
| 2026-07-30 | -17.65 |
| 2026-07-29 | -17.70 |
| 2026-07-28 | -17.69 |
| 2026-07-27 | -17.69 |
| 2026-07-24 | -17.67 |
| 2026-07-23 | -17.65 |
| 2026-07-22 | -17.67 |
| 2026-07-21 | -17.70 |
| 2026-07-20 | -17.70 |
| 2026-07-17 | -17.69 |
| 2026-07-16 | -17.71 |
| 2026-07-15 | -17.70 |
| 2026-07-14 | -17.66 |
| 2026-07-13 | -17.65 |
| 2026-07-10 | -17.64 |
| 2026-07-09 | -17.64 |
| 2026-07-08 | -17.62 |
| 2026-07-07 | -17.63 |
| 2026-07-06 | -8.87 |